Stock Markets Analysis & Opinion

Paycom Software, Inc. (NYSE:PAYC) is set to report third-quarter 2019 results on Oct 29.For the quarter, the company expects revenues in the range of $170-$172 million. The Zacks Consensus Estimate...

Avery Dennison Corporation (NYSE:AVY) reported adjusted earnings of $1.66 per share in third-quarter 2019, which surpassed the Zacks Consensus Estimate of $1.60. The figure also increased around 14%...

Thermo Fisher Scientific Inc.'s (NYSE:TMO) third-quarter 2019 adjusted earnings per share (EPS) came in at $2.94, beating the Zacks Consensus Estimate by 2.1%. The figure also improved from the...

Carlisle Companies Incorporated (NYSE:CSL) reported mixed third-quarter 2019 results, wherein earnings surpassed the Zacks Consensus Estimate but revenues lagged the same.The company’s...

Energy market is uncertain and volatile. Nobody has much visibility into the future. So, when you think of something as a clear line of sight one quarter, it can soon be overshadowed by an unforeseen...

Following Synovus Financial’s (NYSE:SNV) third-quarter 2019 results, its shares have declined 6%. The company reported adjusted earnings of 97 cents per share lagging the Zacks Consensus...

Microsoft Corporation (NASDAQ:MSFT) is set to report first-quarter fiscal 2020 earnings on Oct 23, after market close. The personal computer maker has ventured into the commercial cloud business in...

Edison International (NYSE:EIX) is scheduled to release third-quarter 2019 results on Oct 29, after market close. In the last reported quarter, the company delivered a positive earnings surprise of...

Yamana Gold (AUY) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates --...

Axcelis Technologies (ACLS) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting...

AcelRx Pharmaceuticals (ACRX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces...

Anavex Life Sciences (AVXL) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting...

Investors might want to bet on Applied Optoelectronics (AAOI), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces...

A few chemical companies are gearing up to report their quarterly numbers on Oct 24. Per the Zacks industry classification, the chemical industry is under the broader Basic Materials sector. The Q3...